Skip to main content

Peer Review reports

From: Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma

Original Submission
3 May 2016 Submitted Original manuscript
18 May 2016 Reviewed Reviewer Report - Guru Sonpavde
18 May 2016 Reviewed Reviewer Report - Hiten Patel
20 May 2016 Reviewed Reviewer Report - Brian Hu
20 Jul 2016 Author responded Author comments - Majdi Jebali
Resubmission - Version 2
20 Jul 2016 Submitted Manuscript version 2
17 Aug 2016 Reviewed Reviewer Report - Brian Hu
18 Aug 2016 Reviewed Reviewer Report - Hiten Patel
28 Aug 2016 Reviewed Reviewer Report - Guru Sonpavde
9 Sep 2016 Author responded Author comments - Majdi Jebali
Resubmission - Version 3
9 Sep 2016 Submitted Manuscript version 3
4 Nov 2016 Author responded Author comments - Majdi Jebali
Resubmission - Version 4
4 Nov 2016 Submitted Manuscript version 4
2 Dec 2016 Author responded Author comments - Majdi Jebali
Resubmission - Version 5
2 Dec 2016 Submitted Manuscript version 5
Publishing
13 Dec 2016 Editorially accepted
6 Jan 2017 Article published 10.1186/s12885-016-2993-7

You can find further information about peer review here.

Back to article page